Get documents about "EB meeting 27.09
Document Sample
ERA-NET PathoGenoMics
5th Executing Board Meeting
27th September, Helsinki
Dr. Marion Karrasch-Bott
ERA-NET PathoGenoMics - Joint Secretariat
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
1. Meetings / Reporting
2. Financial status
3. Deliverables and Milestones
4. WP 5: preparation of the partnering event
WP 6: Training and mobility
WP 9: Science and Society
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
Deliv. Deliverable Due Current status Comple- Submission to
No name date tion EC
D 10.3 Consortium MM 12, Consortium management reporting MM 2 MM 3
management 24, 36, (15th Nov 2004)
reporting 48, 60 MM 7 MM 7
All interim reports are available on the internal
(progress and web pages -> (1st Mar 2005)
„Finance-tool“ -> „Goto texts section“
financial reports, MM 12 MM 12
audit certificates) (16th Aug 2005)
Either: -> „view allFinancial reportlist audit certificates due in
tasks“ -> and of all stored texts, including
MM 18, 36 and 60
the interim reports st st
D 10.5 NSC and EB MM 1, 3, The 1 NSC meeting and the 1 EB meeting: MM 2 MM 3
meetings incl. 6, 9, 12, 13 th – 15th October 2004 in Berlin (15th Nov 2004)
Or:
quarterly choose the respective month ->
..., 60
circulars The 2nd EB meeting: MM 5 MM 7
„November 2004“ 20th January inInterim report 11/2004
-> Bonn, Germany (1st Mar 2005)
„March 2005“ -> Interim report 03/2005
The 3rd EB/ 2nd NSC meeting: MM 8 MM 12
„August 2005“ 08/2005
-> Interim report
7th/8th of April in Bonn, Germany (16th Aug 2005)
The 4th EB meeting: MM 10 MM 12
27th/28th of June in Vienna, Austria (16th Aug 2005)
All meeting minutes are available on the internal web pages
The 5th EB/ 3rd NSC meeting:
-> „Meetings“ 26th/27th of September in Helsinki, Finland
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
Meetings
Meeting no. Date place Minutes taker
NSC 1 / EB 1 10/04 Berlin Karrasch
EB 2 01/05 Bonn Glaser/Karrasch
NSC 2 / EB 3 04/05 Bonn Joint secretariat
EB 4 06/05 Vienna Firnberg
NSC 3 / EB 5 09/05 Helsinki Joint secretariat
EB 6 12/05 (Barcelona) Juuti
NSC 4 / EB 7 03-04/06 (Jerusalem) Joint secretariat
EB 8 (06/06) n.d. Allon
NSC 5 / EB 9 (09/06) n.d. Joint secretariat
EB 10 (12/06) n.d. Salas/Barbas
NSC 6 / EB 11 n.d. Joint secretariat
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
1. Meetings
2. Financial status
3. Deliverables and Milestones
4. WP 5: preparation of the partnering event
WP 6: Training and mobility
WP 9: Science and Society
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
Reminder:
- Please enter all your costs into our Finance tool
- Please enter your costs according to the
Workpackages/Tasks (WP 1-9)
- WP 10 (Consortium management): here you enter only
your audit costs (nothing else!)
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
Reporting: what do you have to do?
• enter your expenses in our Finance Tool as
often as necessary (at least monthly)
forgot your passwords: please contact us
• Record your personnel working hours e.g.
via the report Form
(was provided by us and may be provided again if
necessary)
WP 10 („Consortium Management“):
• Here you enter ONLY Work Package
Provide the Task Leaders /YOUR AUDIT COSTS!!!
Leaders with the relevant information
necessary for fulfilling the task
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
Financial Audit after 18 months: 28th February 2006
Deadline for delivery of the audit certificate to the
coordinator: 24th March 2006
Latest date for delivery to the KOM: 45 days after
2006
end of reporting peroid: 14th April prepared
Contact your auditor early enough to be
for delivering your certificate IN TIME
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
Payment schedule
Partner DE AT FI FR HU IL LV PT SV ES Sum
P1 P3 P4 P5 P11/12 P7 P8 P9 P10 P11
1st payment: 80% 415231 88608 172965 143760 67303 130142 70288 70288 70288 84150 1313023 payment after
pre-financing 1st project start
period √ √ √ √ √ √ √ √ √ (except HU)
2nd payment: final 220927 77288 88533 113397 51942 88388 49331 49331 49331 106364 894833 payment after
20% 1st period + submission of
80% pre-financing 1st audit
2nd period certificate
3rd payment: final 149821 109500 37787 82758 35663 75262 30772 30772 30772 76525 659633 payment after
20% 2nd period + submission of
80% pre-financing 2nd audit
3rd period certificate
4th payment: final 30331 24304 6616 15786 2876 15152 5708 5708 5708 18521 130711 payment after
20% 3rd period submission of
3rd audit
certificate
TOTAL added 816311 299700 305900 355701 157784 308944 156100 156100 156100 285560 2998200
TOTAL 812298 269700 266900 385700 252700 311700 156100 156100 156100 232700 3000000
precalculated
difference due to 4013 30000 39000 -30000 -94916 -2757 0 0 0 52860 -1800
reallocations
Partner DE AT FI FR HU IL LV PT SV ES Sum
M. Karrasch, FZJ
27.09.2005
PathoGenoMics
ERA-NET versus actual costs
Overview month 1-24:
precalculated
Budget;
costs (€) Costs
Precalculated DE
budget AT
200.000
FI
IL
LV
ES
100.000
0
M. Karrasch, FZJ
4 8 12 16 20 24 months
27.09.2005
PathoGenoMics
ERA-NET versus actual costs
Overview month 1-60:
precalculated
Budget;
costs (€) DE
800.000
Plus
Foresight
study
Without
Foresight
study
400.000
months
M. Karrasch, FZJ
0 12 24 36 48 60
27.09.2005
PathoGenoMics
ERA-NET versus actual costs
Overview month 1-60:
precalculated
300.000
Budget;
costs (€)
AT
FI
IL
200.000 LV
ES
100.000
M. Karrasch, FZJ
27.09.2005
0 12 24 36 48 60 months
ERA-NET PathoGenoMics
Budget and costs (€)
3.000.000
2.000.000
1.000.000
Estimated
based on the costs
of AT, FI, DE, IL, LV and ES
M. Karrasch, FZJ
27.09.2005
0 12 24 36 48 60 months
ERA-NET PathoGenoMics
1. Meetings
2. Financial status
3. Deliverables and Milestones
4. WP 5: preparation of the partnering event
WP 6: Training and mobility
WP 9: Science and Society
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
Timetable Deliverables: due dates
Month 12 24 36 48 60
D 1.1 D 1.2 D 1.3
D 2.1, 2.2, 2.3
D 2.4
D 3.1
D 3.2
D
D 3.3 3.3
D 4.1
D 4.2, 4.3
D 5.1 D 5.2
D 6.1
D 6.2
D 7.1, 7.2, 7.3
D 7.4
D 8.1 D 8.1
D 8.2 D 8.2
D 8.3 D 8.3, 8.4 D 8.4 D 8.4
D 9.1, 9.2
D 9.2 D 9.2 D 9.2 D 9.2 D 9.2
D 10.1, 10.2
D 10.3 D 10.3 D 10.3
D 10.4
D 10.5
M. Karrasch, FZJ
27.09.20050 12 24 36 48 60
ERA-NET PathoGenoMics
Timetable Deliverables: completion dates
Month 12 24 36 48 60
D 1.1 D 1.2 D 1.3
D 2.1, 2.2, 2.3
D 2.4
D 3.1
D 3.2
D
D 3.3 3.3
D 4.1
D 4.2, 4.3
D 5.1 D 5.2
D 6.1
D 6.2
D 7.1, 7.2, 7.3
D 7.4
D 8.1 D 8.1
D 8.2 D 8.2
D 8.3 D 8.3, 8.4 D 8.4 D 8.4
D 9.1, 9.2
D 9.3 D 9.3 D 9.3 D 9.3 D 9.3
D 10.1, 10.2
D 10.3 D 10.3 D 10.3
D 10.4
D 10.5
M. Karrasch, FZJ
27.09.20050 12 24 36 48 60
ERA-NET PathoGenoMics
1. Meetings
2. Financial status
3. Deliverables and Milestones
4. WP 5: preparation of the partnering event
WP 6: Training and mobility
WP 9: Science and Society
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
Suggestions for the 6th EB meeting:
Date: Friday, 2nd December 2005 (arrival on the 1st December)
Place: Barcelona
Potential topics:
- Project management of the first joint call
e.g. amendments / changes to the call addenda
- Preparation of the WP 4 activities (PIP network etc.)
- Finalization of WP 3 (Strategic Research Agenda)
- Preparation of the Israel meeting (NSC 4, EB 7)
back
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
Suggestions for the 4th NSC / 7th EB meeting:
Date: Monday, 3rd April 2006 – Tuesday, 4th April 2006
(arrival on the 2nd April)
Place: Jerusalem
Potential topics:
- first discussion of the received proposals from the first joint call
- preparation of the evaluation session
- preparation of the second joint call
back
M. Karrasch, FZJ
27.09.2005
ERA-NET PathoGenoMics
Timetable Deliverables: completion dates
Month 12 24 36 48 60
D 1.1 D 1.2 D 1.3
D 2.1, 2.2, 2.3
D 2.4
D 3.1
D 3.2
D 3.3 3.3
D D 3.2: Minutes from expert workshop
D 4.1 1 per session (Paris, May 05)
D 4.2, 4.3 Due date: MM 9
Completion date: MM 13
D 5.1 D 5.2
D 6.1
D 6.2 D 3.3: European Research Agenda
D 7.1, 7.2, 7.3 1. published draft 2. final version
Due dates:
D 7.4
D 8.1 D 8.1 1. MM 11 2. MM 15
D 8.2 8.2
DApprox. Completion dates:
D 8.3 D 8.3, 8.4 ?
1. MM 13 D
D 8.4 2. MM 17 ?8.4
D 9.1, 9.2
D 9.3 D 9.3 D 9.3 D 9.3 D 9.3
D 10.1, 10.2
D 10.3 D 10.3 D 10.3
D 10.4
D 10.5
M. Karrasch, FZJ
27.09.20050 12 24 36 48 60 back
ERA-NET PathoGenoMics
Timetable Deliverables: WP 4:
completion dates
Month for
Stimulating the environment 36 a wider exploitation and job
12 24 48 60
D 1.1 D 1.2 D 1.3
creation
D 2.1, 2.2, 2.3 Deliv. Deliverable name Due Current Approx.
D 2.4 No date status Comple-
(DoW) tion
D 3.1
D 3.2 D 4.1 Strategy paper MM 13 1st MM 17
D
D 3.3 3.3 “Innovation potentials presentation
D 4.1 & perspectives in planned in
D 4.2, 4.3 pathogenomics” MM 13
D 4.2
D 5.1 Supporting network of MM 15 1st PIP
D 5.2 MM 17
innovation partners
D 6.1 meeting
D 6.2 (PIPs) incl. planned for
D 7.1, 7.2, 7.3 minutes of 5 annual MM 17
meetings (MM 15, 24,
D 7.4
D 8.1 36, 48, 60)
D 8.1
D 8.2 D 8.2
D 4.3 Web-based innovation MM 15 Will be
D 8.3 D 8.3, 8.4 D 8.4 D 8.4
market delayed due
D 9.1, 9.2
(including to delay in D
D 9.3 D 9.3
D 9.3 multiplication system) D 9.3 D 4.2
4.1 and9.3
D 10.1, 10.2
D 10.3 D 10.3 D 10.3
D 10.4
D 10.5
M. Karrasch, FZJ
27.09.20050 12 24 36 48 60 back
ERA-NET PathoGenoMics
Timetable Deliverables: completion dates
Month 12 24 36 48 60
D 1.1 D 1.2 D 1.3
D 2.1, 2.2, 2.3
D 2.4
D 5.1: Partnering workshop in Helsinki
D 3.1
Due date: MM 13
D 3.2
D
D 3.3 3.3 current status:
D 4.1
Planned for Feb. 06
D 4.2, 4.3 in collaboration with NoE “EuroPathogenomics”;
D 5.1 D 5.2 approx. 2 months after call publication;
probably not in Helsinki
D 6.1
D 6.2
D 7.1, 7.2, 7.3
D 7.4
D 8.1 D 8.1
D 8.2 D 8.2
D 8.3 D 8.3, 8.4 D 8.4 D 8.4
D 9.1, 9.2
D 9.3 D 9.3 D 9.3 D 9.3 D 9.3
D 10.1, 10.2
D 10.3 D 10.3 D 10.3
D 10.4
D 10.5
M. Karrasch, FZJ
27.09.20050 12 24 36 48 60 back
ERA-NET PathoGenoMics
Timetable Deliverables: completion dates
Month 12 24 36 48 60
D 1.3
D 1.1 D 1.2 D 9.1: IT-based communication and information platform
D 2.1, 2.2, 2.3
(with media service, archive, event calendars, etc.)
D 2.4 Due date: MM 9
D 3.1 current status:
PathoGenoMics web pages publicly accessible since
D 3.2
10th of October 2004. Communication and information
D
D 3.3 3.3
platform is being programmed at the moment;
D 4.1
presumably be available in September 2005
will D 4.2, 4.3
D 9.2: D 5.1 D 5.2
Printed information material
D 6.1
(e.g. teaching aids, annual reports, brochures, leaflets)
D 6.2
Due date: MM 9
D 7.1, 7.2, 7.3
Current status:
D 7.4
First brochure about the PathoGenoMics ERA-NET is
D 8.1 D 8.1
available in August 2005 D 8.2
D 8.2
D 8.3 D 8.3, 8.4 D 8.4 D 8.4
D 9.1, 9.2
D 9.3 D 9.3 D 9.3 D 9.3 D 9.3
D 10.1, 10.2
D 10.3 D 10.3 D 10.3
D 10.4
D 10.5
M. Karrasch, FZJ
27.09.20050 12 24 36 48 60 back
ERA-NET PathoGenoMics
Timetable Deliverables: completion dates
Month 12 24 36 48 60
D 1.1 D 1.2 D 1.3
D 2.1, 2.2, 2.3
D 2.4
D 3.1
D 3.2
D
D 3.3 3.3
D 4.1
D 4.2, 4.3
D 9.3: On-spot presentations
D 5.2
D 5.1 (annually, at special events)
D 6.1
Due dates: MM 10, 19, 32, 43, 55)
D 6.2
D 7.1, 7.2, 7.3 Completion dates: ?
D 7.4
D 8.1 D 8.1
D 8.2 D 8.2
D 8.3 D 8.3, 8.4 D 8.4 D 8.4
D 9.1, 9.2
D 9.3 D 9.3 D 9.3 D 9.3 D 9.3
D 10.1, 10.2
D 10.3 D 10.3 D 10.3
D 10.4
D 10.5
M. Karrasch, FZJ
27.09.20050 12 24 36 48 60 back
